Bill > SR112

This Resolution urges the Biden Administration to lift a regulatory freeze on executive orders, specifically Executive Orders 13937, 13838, 13939, and 13947 from 2020, which were designed by the Trump Administration to significantly reduce the cost of essential prescription drugs for Americans, such as insulin and epinephrine. These executive orders aimed to achieve lower drug prices by ending kickbacks from middlemen, allowing federal community health centers to pass on discounts directly to patients, enabling the safe importation of drugs from countries where they are cheaper, and ensuring that Medicare and seniors do not pay more for drugs than individuals in comparable economically developed nations, thereby addressing the issue of Americans subsidizing global drug research and development costs. The resolution highlights that the Biden Administration's regulatory freeze has put millions of Americans, including seniors, the impoverished, and the uninsured, at risk by delaying these cost-saving measures.